The Service of the Commission for the Protection of Competition has received a notification of a concentration, according to Section 10 (4) of the Control of Concentrations between Enterprises Law of 2014, concerning the acquisition by BC Partners LLP of Synthon International Holding B.V.’s share capital, via Stamina BidCo B.V.
Synthon International Holding B.V., is duly registered under provisions of the Laws of the Netherlands and it is active in the development, manufacture, packaging, licensing and distribution of complex generic end-dose pharmaceuticals. Synthon also manufactures pharmaceutical ingredients used in its products.
Stamina BidCo B.V. is duly registered under provisions of the Laws of the Netherlands and it is a special vehicle company that is own by BC European Capital X investment fund. This fund is consulted by BC Partners LLP, which also provides investment advice on some other private equity funds (the “BC Funds”).
BC Partners LLP is a limited liability company registered under the United Kingdom law. BC Partners is a private equity firm that advises BC Funds - including the BC European Capital X Fund - that invest, acquire and develop European, North American or multinational companies to create value, in partnership with management.